10:36 AM EST - Bausch Health Companies Inc. : Announced its Bausch + Lomb division has received approval from Australia's Therapeutic Goods Administration (TGA) for the supply of BAUSCH + LOMB ULTRA® ONE DAY daily disposable silicone hydrogel (SiHy daily) contact lenses. Bausch + Lomb anticipates that BAUSCH + LOMB ULTRA® ONE DAY lenses will be available to selected practitioners in Australia beginning in the fourth quarter of 2020 with a national launch in early 2021. Bausch Health Companies Inc.
shares T.BHC are trading down $0.47 at $23.09.
